Cantú LD, Mohar A, Herrera LA

Language: Spanish
References: 8
Page: 555-557
PDF size: 156.16 Kb.

Text Extraction

No abstract

REFERENCES

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA Cancer J Clin 2011; 61(2): 69-90.

2. Reporte Histopatológico de Neoplasias Malignas 2003.

3. Centers for Disease Control and Prevention US Cancer Statistics: 1999- 2005. Cancer incidence and mortality data US Department of Health and Human Services. 2009.

4. Clarke-Pearson D. Clinical practice. Screening for ovarian cancer. N Engl J Med 2009; 361(2): 170-7.

5. Russo A, Calo V, Bruno L, Rizzo S, Bazan V, Di Fede G. Hereditary ovarian cancer. Crit Rev Oncol Hematol 2009; 69: 28-44.

6. Auersperg N. The origin of ovarian carcinomas: a unifying hypothesis. Inter J Gynecol Pathol 2011; 30(1): 12- 21.

7. Zaino RJ, Brady MF, Lele SM, Michael H, Greer B, Bookman MA. Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study. Cancer 2011; 117(3): 554-61.

8. Morgan RJ Jr. Ovarian cancer guidelines: treatment progress and controversies. J Natl Compr Canc Netw 2011; 9(1): 4-5.